메뉴 건너뛰기




Volumn 8, Issue 4, 2004, Pages 628-642

Development of a manufacturing process for sibenadet hydrochloride, the active ingredient of viozan

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 7 [2 [2 [3 (2 PHENYLETHOXY)PROPYLSULFONYL]ETHYLAMINO]ETHYL] BENZOTHIAZOL 2(3H) ONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; SIBENADET; UNCLASSIFIED DRUG;

EID: 4243195881     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op049953y     Document Type: Article
Times cited : (32)

References (26)
  • 7
    • 0000935422 scopus 로고
    • Fuji, K.; Ueda, M.; Sumi, K.; Kajiwara, K.; Fujita, E.; Iwashita, T.; Miura, I. J. Org. Chem. 1985, 50, 657. This paper describes a low-yielding preparation of 11 by alkylation of 2-lithio-1,3-oxathiane with benzyl bromide. We have found that condensation of phenylacetaldehyde with 3-mercapto-1-propanol under standard acid-catalyzed Dean-Stark distillation conditions gives 11 in good yield.
    • (1985) J. Org. Chem. , vol.50 , pp. 657
    • Fuji, K.1    Ueda, M.2    Sumi, K.3    Kajiwara, K.4    Fujita, E.5    Iwashita, T.6    Miura, I.7
  • 22
    • 4243138758 scopus 로고    scopus 로고
    • (AstraZeneca AB). WO 00/50413 Al
    • Eyley, S. (AstraZeneca AB). WO 00/50413 Al.
    • Eyley, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.